Sign in

CIK 0001817229 · <br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 4 Open-market sale 10% owner sold 447,278 shares at $1.54 ($688,853)
  2. 4 Open-market sale 10% owner sold 984,805 shares at an average $1.73 ($1,703,971)
  3. 4 Open-market sale 10% owner sold 1,263,647 shares at an average $1.95 ($2,457,975)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale 10% owner sold 1,407,628 shares at an average $1.97 ($2,767,982)
  8. 4 Open-market sale 10% owner sold 1,417,998 shares at an average $2.01 ($2,848,511)
  9. 4 Open-market sale 10% owner sold 671,536 shares at an average $2.10 ($1,411,083)
  10. 4 Grant or award Chief Development Officer acquired 937,080 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award CFO acquired 13,882,750 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 3 of 11 · 212 filings